Not surprising: a rebound in antibacterial consumption in Europe, with Cyprus and Greece on the podium.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
    • Publication Information:
      Publication: 1997- : London : Oxford University Press
      Original Publication: London, New York, Academic Press.
    • Subject Terms:
      Anti-Bacterial Agents*/therapeutic use ; Drug Utilization*/statistics & numerical data; Humans ; Cyprus ; Greece ; Bacterial Infections/drug therapy
    • Abstract:
      Recent European-wide data place Cyprus and Greece in the highest positions of total antimicrobial consumption. While this level of consumption might be partly attributed to the high rates of infections due to MDR bacteria in these countries, several other reasons should be sought to help apply local measures, to decrease inappropriate and excess antimicrobial use. The present viewpoint aims to provide a roadmap for interventions, by briefly discussing the various factors that underlie antimicrobial use and prescribing practices in Greece and Cyprus.
      (© The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.)
    • References:
      Euro Surveill. 2022 May;27(19):. (PMID: 35551702)
      Build Environ. 2022 Aug 15;222:109366. (PMID: 35818484)
      J Glob Antimicrob Resist. 2014 Mar;2(1):11-16. (PMID: 27873631)
      J Antimicrob Chemother. 2022 Apr 27;77(5):1491-1499. (PMID: 35178565)
      J Glob Antimicrob Resist. 2020 Jun;21:296-302. (PMID: 31726237)
      Cochrane Database Syst Rev. 2023 Jan 30;1:CD006207. (PMID: 36715243)
      Lancet Digit Health. 2021 Jun;3(6):e360-e370. (PMID: 34045002)
      Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2061-2068. (PMID: 31396830)
      Antibiotics (Basel). 2020 Oct 30;9(11):. (PMID: 33143207)
      Lancet Microbe. 2023 May;4(5):e293. (PMID: 36933564)
      EClinicalMedicine. 2023 Mar;57:101848. (PMID: 36776504)
      JAMA Netw Open. 2024 Jan 2;7(1):e2350061. (PMID: 38170521)
    • Accession Number:
      0 (Anti-Bacterial Agents)
    • Publication Date:
      Date Created: 20240305 Date Completed: 20240501 Latest Revision: 20240724
    • Publication Date:
      20240725
    • Accession Number:
      PMC11062937
    • Accession Number:
      10.1093/jac/dkae055
    • Accession Number:
      38442334